Dr Takashi Itokawa describes findings from a recent study evaluating ocular surface temperature, conjunctival blood flow, and ...

In terms of negative impact, some patients showcased side effects, but most were from the surgery. Some participants suffered ...

The patient with the Clade 1b strain is a 38-year-old male patient from Kerala who tested positive last week. The patient is ...

A subretinal gene therapy was well tolerated 1 year after treatment, with no drug-related serious adverse events, in a small ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Patients with a rare inherited disease affecting their sight experienced quick vision improvements that sustained for a year.

Researchers at the Perelman School of Medicine at the University of Pennsylvania have reported improvements in vision among ...

But now people with a rare inherited condition that causes them to lose much of their vision during childhood, there is new ...

The US Centers for Disease Control and Prevention (CDC) has issued a warning about the rise in Oropouche virus disease cases ...

With Oropouche virus cases reported in the US and Europe OnlyMyHealth interacted with an expert to understand the disease ...

Johnson & Johnson (NYSE:JNJ) today announced new data from the Phase 1b/2 OrigAMI-1 study, which showed RYBREVANT® (amivantamab-vmjw) combined with chemotherapy (mFOLFOX6 [FOLFOX] or FOLFIRI) ...